Evaluating Cross-Cutting Prevention at the U.S. Air Force Academy
Launched by RTI INTERNATIONAL · Mar 7, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Sexual assault and alcohol misuse both persist at high rates among military populations. These behaviors interfere with readiness, unit cohesion, mission objectives, and personnel performance and retention. There are demonstrated associations between sexual assault and alcohol misuse for both perpetrators and victims of sexual assault. Therefore, combining efforts to prevent sexual assault and alcohol misuse is critical for more effective and efficient programming. Moreover, tailored prevention programming that addresses individual risks and experiences related to sexual assault and alcohol...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • U.S. Air Force Academy Basic Cadet enrolled in 2022 or 2023 Basic Cadet Training
- Exclusion Criteria:
- • Unable or unwilling to provide informed consent
About Rti International
RTI International is a leading nonprofit research institute dedicated to improving the human condition through innovative scientific research and technical assistance. With a strong focus on health and social science, RTI collaborates with various stakeholders, including government agencies, private organizations, and academic institutions, to advance knowledge and drive impactful solutions. The organization is recognized for its rigorous methodologies and commitment to ethical research practices, making it a trusted sponsor for clinical trials aimed at enhancing public health and advancing medical science. Through its comprehensive approach, RTI International contributes to the development of evidence-based strategies that address pressing health challenges globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Air Force Academy, Colorado, United States
Patients applied
Trial Officials
Marni L Kan, PhD
Principal Investigator
RTI International
Nichole M Scaglione, PhD
Principal Investigator
University of Florida
Emily A Schmied, PhD
Principal Investigator
San Diego State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported